Hervé Geneste

This inventor holds 33 USPTO granted patents and 15 published patent applications and 20 EPO patents. Top assignees: Abbvie Deutschland Gmbh and Co Kg, Abbott Gmbh & Co Kg, Abbvie Inc.. Active years: 2005-2019.

USPTO Granted Patents = 33 (Patent Applications = 15)

% Patents Active = 39.4

EPO Patents = 20 (Patent Applications = 25)

Average Co-Inventor Count = 6.4

ph-index = 5

Forward Citations = 103(Granted Patents)

Location History:

Neuhofen, DE (2005 - 2012)
Wiesbaden, DE (2017)
Ludwigshafen, DE (2012 - 2019)

Company Filing History:

19 out of 167

Abbvie Deutschland Gmbh and Co Kg

4. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 2005-2019

Loading Chart...

Areas of Expertise:

Phosphodiesterase Type 10A

Oxindole Derivatives

Vasopressin-Related Diseases

Fused Heterocyclic Compounds

Dopamine D3 Receptor

Integrin Receptors Antagonists

Metabotropic Glutamate Receptors

Substituted Isoquinolines

Heteroaryl-Substituted Compounds

Carbamate-Substituted Derivatives

Triazole Compounds

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10308610 - Inhibitor compounds of phosphodiesterase type 10A (2019-06-04),

2. 10160744 - [object Object] (2018-12-25),

3. 9938269 - Inhibitor compounds of phosphodiesterase type 10A (2018-04-10),

4. 9862704 - Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substituent and use thereof for treating vasopressine-related diseases (2018-01-09),

5. 9856220 - Inhibitor compounds of phosphodiesterase type 10A (2018-01-02),

6. 9840495 - Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases (2017-12-12),

7. 9790203 - Inhibitor compounds of phosphodiesterase type 10A (2017-10-17),

8. 9688678 - Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof for treating vasopressin-related diseases (2017-06-27),

9. 9657034 - Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitors (2017-05-23),

10. 9617226 - Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases (2017-04-11),

11. 9527856 - Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseases (2016-12-27),

12. 9487505 - Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them (2016-11-08),

13. 9475808 - Inhibitor compounds of phosphodiesterase type 10A (2016-10-25),

14. 9464085 - Inhibitor compounds of phosphodiesterase type 10A (2016-10-11),

15. 9422264 - Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases (2016-08-23),

Title: Inspiring Innovation: The Journey of Hervé Geneste in Shaping Future Technology

Introduction:

Hervé Geneste, a visionary inventor based in Ludwigshafen, DE, has left an indelible mark on the world of technology with his passion for innovation and relentless pursuit of advancement. His remarkable journey continues to inspire the next generation of inventors and reshape the landscape of technology.

Latest Patents:

With an impressive portfolio of 33 patents, Hervé Geneste's latest inventions demonstrate his pioneering spirit. His recent patents include "Inhibitor compounds of phosphodiesterase type 10A" and "[object Object]", both of which have significant implications in the treatment of neurological and psychiatric disorders.

Career Highlights:

Having worked in renowned companies such as AbbVie Deutschland GmbH & Co. KG and Abbott GmbH & Co. KG, Hervé Geneste has gained invaluable experience and expertise in the field of technology and pharmaceuticals. His innovative mindset and dedication to pushing boundaries have led to groundbreaking discoveries.

Collaborations:

Throughout his career, Hervé Geneste has collaborated with esteemed professionals in the industry, including Wilfried Hornberger and Karla Drescher. These fruitful collaborations have not only enriched his work but have also paved the way for new insights and advancements in technology.

Conclusion:

In conclusion, Hervé Geneste's remarkable contributions to the world of technology underscore his unwavering commitment to innovation and progress. His groundbreaking inventions, combined with his collaborative spirit, have positioned him as a true pioneer in shaping the future of technology. As his legacy continues to inspire and influence the next generation of inventors, Hervé Geneste remains a driving force in the ever-evolving world of innovation.